Sarah Evans considers herself a lucky ovarian cancer patient, though she is dealing with the second recurrence of the disease since she was first diagnosed in February 2018.She is grateful that, even by her third round of chemo in March of this year, her cancer was still responding to carboplatin treatment — the most common […]
